2021 annual financial data

Cellectar Biosciences, Inc. 2021 Operating margin

Cellectar Biosciences, Inc. 2021 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -24,131,280 USD and net income was -23,970,163 USD.
Operating cash flow was -22,568,838 USD.

Get free Cellectar Biosciences, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-24,131,280 USD
Net income
-23,970,163 USD
Operating cash flow
-22,568,838 USD